GCG and type 2 diabetes mellitus: GLP-1 is an attractive therapeutic target for type 2 diabetes because of its important actions, including stimulation of insulin biosynthesis and secretion, inhibition of glucagon secretion, inhibition of gastric emptying and acid secretion, reduction of food intake, and expansion of beta-cell mass in the pancreas (see review) [1].